OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current challenges and future opportunities in patient‐focused management of hereditary angioedema: A narrative review
Anete Sevciovic Grumach, Noga Gadir, Aharon Kessel, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 6
Anete Sevciovic Grumach, Noga Gadir, Aharon Kessel, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 6
Showing 6 citing articles:
Effective long‐term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER /ENABLE
Raffi Tachdjian, Aleena Banerji, Paula Busse, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 4
Open Access | Times Cited: 1
Raffi Tachdjian, Aleena Banerji, Paula Busse, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 4
Open Access | Times Cited: 1
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab
Petra Staubach, Timothy Craig, Tomoo Fukuda, et al.
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 3, pp. 200-208
Closed Access | Times Cited: 1
Petra Staubach, Timothy Craig, Tomoo Fukuda, et al.
Allergy and Asthma Proceedings (2025) Vol. 46, Iss. 3, pp. 200-208
Closed Access | Times Cited: 1
Comparison of real-world healthcare resource utilization and costs among patients with hereditary angioedema on lanadelumab or berotralstat long-term prophylaxis
Nicole Princic, Kristin Evans, Chintal H. Shah, et al.
Journal of Comparative Effectiveness Research (2025)
Open Access
Nicole Princic, Kristin Evans, Chintal H. Shah, et al.
Journal of Comparative Effectiveness Research (2025)
Open Access
Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses
Jonathan A. Bernstein, Navid Ziaie, Roberta Fachini Jardim Criado, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2251-2263
Closed Access | Times Cited: 9
Jonathan A. Bernstein, Navid Ziaie, Roberta Fachini Jardim Criado, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2251-2263
Closed Access | Times Cited: 9
Targeting factor XIIa for therapeutic interference with hereditary angioedema
Danny M. Cohn, Thomas Renné
Journal of Internal Medicine (2024) Vol. 296, Iss. 4, pp. 311-326
Open Access | Times Cited: 3
Danny M. Cohn, Thomas Renné
Journal of Internal Medicine (2024) Vol. 296, Iss. 4, pp. 311-326
Open Access | Times Cited: 3
Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1491-1492
Closed Access | Times Cited: 2
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 11, pp. 1491-1492
Closed Access | Times Cited: 2
The latest therapeutic reports on short-term and long-term prophylaxis in the treatment of hereditary angioedema
Maciej F. Kozlowski, Karolina Żurawska, Iwona Poziomkowska‐Gęsicka
Alergologia Polska - Polish Journal of Allergology (2024) Vol. 11, Iss. 1, pp. 56-60
Open Access
Maciej F. Kozlowski, Karolina Żurawska, Iwona Poziomkowska‐Gęsicka
Alergologia Polska - Polish Journal of Allergology (2024) Vol. 11, Iss. 1, pp. 56-60
Open Access
